- Home
- KPTI vs ONL Comparison
KPTI vs ONL Comparison
Compare KPTI & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | ONL |
|---|---|---|
| Founded | 2008 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 149.2M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KPTI | ONL |
|---|---|---|
| Price | $5.34 | $1.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $15.33 | $3.00 |
| AVG Volume (30 Days) | ★ 1.3M | 277.7K |
| Earning Date | 05-11-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $146,067,000.00 | ★ $147,647,000.00 |
| Revenue This Year | N/A | $4.10 |
| Revenue Next Year | $46.62 | $3.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.51 | $1.46 |
| 52 Week High | $10.99 | $3.01 |
Technical Indicators
Market Signals| Indicator | KPTI | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 29.62 | 32.03 |
| Support Level | $3.93 | $1.63 |
| Resistance Level | $6.82 | $2.67 |
| Average True Range (ATR) | 0.86 | 0.11 |
| MACD | -0.36 | -0.04 |
| Stochastic Oscillator | 9.41 | 4.39 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.